Antibiotic prophylaxis in cirrhosis: Good and bad-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibiotic prophylaxis in cirrhosis: Good and bad

Published:2016-01-11 Issue:6 Volume:63 Page:2019-2031
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fernández Javier¹²³,Tandon Puneeta⁴,Mensa Jose⁵,Garcia-Tsao Guadalupe⁶⁷

Affiliation:

1. Liver Unit, Hospital Clinic; University of Barcelona; Barcelona Spain

2. Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS); Barcelona Spain

3. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHED); Barcelona Spain

4. Cirrhosis Care Clinic, Cirrhosis Care, Liver Unit, Division of Gastroenterology; University of Alberta; Edmonton Canada

5. Infectious Disease Department, Hospital Clínic; University of Barcelona; Barcelona Spain

6. Section of Digestive Diseases; Yale University School of Medicine; New Haven CT

7. Section of Digestive Diseases; VA-CT Healthcare System; West Haven CT

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28330/fullpdf

Reference74 articles.

1. Management of bacterial infections in cirrhosis;Fernandez;J Hepatol,2012

2. Severe sepsis in cirrhosis;Gustot;Hepatology,2009

3. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study;Fernández;Hepatology,2012

4. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013;Jalan;J Hepatol,2014

5. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial;Hou;Hepatology,2004

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of rifaximin in liver diseases;Biomedicine & Pharmacotherapy;2024-09

2. Development and validation of prediction models for nosocomial infection and prognosis in hospitalized patients with cirrhosis;Antimicrobial Resistance & Infection Control;2024-08-07

3. A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage;American Journal of Gastroenterology;2024-05-25

4. Decompensated cirrhosis and antibiotic prophylaxis: striking a delicate balance;The Korean Journal of Internal Medicine;2024-05-01

5. Five-year Trends of Fungal Infections in Cirrhotic Patients: Nationwide Study From 2016-2020;2024-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3